Article Details

Acceleron Pharma (NASDAQ:XLRN) Price Target Raised to $135.00 at Morgan Stanley

Retrieved on: 2020-12-16 17:14:50

Tags for this article:

Click the tags to see associated articles and topics

Acceleron Pharma (NASDAQ:XLRN) Price Target Raised to $135.00 at Morgan Stanley. View article details on hiswai:

Excerpt

<b>Morgan Stanley's</b> price target suggests a potential upside of 5.44% from the company's previous close. Several other equities research analysts have ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up